ClearPoint Neuro, Inc. (CLPT)

Market Cap	428.80M
Revenue (ttm)	30.43M
Net Income (ttm)	-18.15M
Shares Out	27.58M
EPS (ttm)	-0.69
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	256,565
Open	14.56
Previous Close	14.66
Day's Range	14.29 - 15.78
52-Week Range	5.11 - 17.47
Beta	1.07
Analysts	Strong Buy
Price Target	12.00 (-22.8%)
Earnings Date	Nov 7, 2024

About CLPT

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; li...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 107
• Stock Exchange: NASDAQ
• Ticker Symbol: CLPT
• Website: https://www.clearpointneuro.com

Financial Performance

In 2023, ClearPoint Neuro's revenue was $23.96 million, an increase of 16.56% compared to the previous year's $20.55 million. Losses were -$22.09 million, 34.4% more than in 2022.

Analyst Forecast

According to 2 analysts, the average rating for CLPT stock is "Strong Buy." The 12-month stock price forecast is $12.0, which is a decrease of -22.80% from the latest price.

Price Target

$12.0

(-22.80% downside)

Analyst Consensus: Strong Buy